Dr. Anton Melnyk
Claim this profileTexas Cancer Center - Abilene
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
2 reported clinical trials
5 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage IV
HER2 positive
2Lung Cancer
Affiliated Hospitals
More about Anton Melnyk
Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Anton Melnyk has experience with
- Canakinumab
- Placebo
- Fulvestrant
- Trastuzumab
- Tucatinib
Breakdown of trials Anton Melnyk has run
Non-Small Cell Lung Cancer
Cervical Cancer
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anton Melnyk specialize in?
Anton Melnyk focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Anton Melnyk currently recruiting for clinical trials?
No, Anton Melnyk is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Anton Melnyk has studied deeply?
Yes, Anton Melnyk has studied treatments such as Canakinumab, Placebo, Fulvestrant.
What is the best way to schedule an appointment with Anton Melnyk?
Apply for one of the trials that Anton Melnyk is conducting.
What is the office address of Anton Melnyk?
The office of Anton Melnyk is located at: Texas Cancer Center - Abilene, Abilene, Texas 79606 United States. This is the address for their practice at the Texas Cancer Center - Abilene.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.